 |
| october
23, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Accent Therapeutics: Presents New
Preclinical Data on Lead Clinical Programs
ATX-295 and ATX-559 at the 2025 AACR-NCI-EORTC
International Conference on Molecular Targets
and Cancer Therapeutics More
- Akari Therapeutics: Launch of CEO Corner
Platform More
- Alloy Therapeutics: Acquisition of
Spannerwerks, a Leading Provider of Drug
Development Consulting Services More
- Clairity: Showcases Demonstration of
CLAIRITY BREAST on NBC’s TODAY Show More
- Generation Bio: CEO Transition More
- Ginkgo Bioworks: Partnership With STRM.BIO
and University of British Columbia in Project
to Develop In Vivo CAR Therapies Under
ARPA-H's EMBODY Program More
- Harbour BioMed: Positive Phase II Results
for HBM4003 and Tislelizumab Combination in
MSS mCRC More
- Insulet: Appointment of Robert L. Huffines
to Its Board of Directors More
- Ipsen: Launches Educational Initiative to
Support Teens and Young Adults Moving From
Pediatric to Adult Healthcare More
- ProMIS Neurosciences: Strengthens Board With
Appointment of Slanix Paul Alex, Pharm.D.,
President and Portfolio Manager, Public Equity
of Ally Bridge Group More
- Sail Biomedicines: Appoints Martin Mackay,
Ph.D., to Its Board of Directors More
- Sironax: Key Leadership Appointments to
Advance Global Drug Discovery and Development
More
- Tango Therapeutics: Reports Positive Data
From Ongoing Phase 1/2 Study With Vopimetostat
(TNG462) in Patients With MTAP-deleted Cancers
More
|
|
 |
 |
The
Charles River CFO Advantage
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
|
- BYTE51:
Exclusive Pricing on Private Biotech &
VC Intelligence More
- Enveric Biosciences: Reverse Stock Split More
- Exclusive: AstraZeneca-Partnered Pinetree
Nears $47M Series B for Protein Degraders More*
- Genmab Was One of Three Bidders Before
Inking $8B Merus Acquisition More*
- More on Flagship Betting Again on AI With
Expedition More
More
- More on Takeda Paying Innovent $1.2B
Upfront, Offering Whopping $10B-Plus in
Biobucks for Cancer Assets More
More
More
More*
- Polaris Partners Plans to Raise $500M for
Latest Biotech Fund More*
More*
- Tango Therapeutics: $225 Million
Financing More
|
|
 |
|
- BiotechTV: Ahead of a Year of Increased
Clinical Activity, Entrada Therapeutics’ CEO
Dipal Doshi Discusses the Company’s EEV
Platform, DMD Programs, and a Vertex
Partnership in DM1 Video
- BiotechTV: Disc Medicine CEO John Quisel
Describes the Process of Becoming Among the
First Companies to Receive FDA’s New
Commissioner’s National Priority Voucher
(CNPV) Video
- Moderna: Reflecting on Phase 3 CMV
Vaccine Readout More
More
More*
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Wyss: Crossing the Barrier - Wyss Brain
Targeting Program is Delivering on Its Promise
More
- Wyss:
Haritosh Patel on Sniffing Out a Solution to
Indoor Air Pollution More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- Elevating Executive Presence: A Blueprint
for Life Sciences and Biotech Leaders More
- BBJ’s Women Who Lead in Life Sciences Offer
Career Advice in Tough Times More*
- CEO’s Perspective: Big Moves Come with Big
Responsibility More
- CEO’s Perspective: The High Cost of Job
Hopping More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- Shape’s Former CSO Picks Up Tech Role at
Moderna; Lilly Reels In Peter Marks More*
- What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Biocom California CEO Summit (Bay
Area/Wine Country) Oct
24
- 15th Annual PODD Conference Oct
27-28
- New Jersey Life Sciences & Biotech
Conference Oct
28
- Biocom California CEO Summit (Los
Angeles) Oct
29
- Meet the Experts | ADME & DMPK Nov
6
- Pantheon 2025 Nov
6
- BIO-Europe 2025 Nov
11-12
- Copay, Reimbursement and Access Congress
(Save 10% with VIP code: 25B4B10) Nov
18-20
- Pharma/Biotech Gross-To-Net Summit (Save 10%
with VIP code: 25B4B10) Nov
18-20
- Patient Support Services Congress (Save 10%
with VIP code: 25B4B10) Nov
20-21
- Compounding Pharmacy Compliance (Save 10%
with VIP code: 25B4B10) Dec
9-10
- Trade and Channel Strategies (Save 10% with
VIP code: 25B4B10) Dec
9-11
- Advancing Drug Development Forum Dec
11
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
